Publication List 2004-2006

1. Chiba, A., S. Oki, K. Miyamoto, H. Hashimoto, T. Yamamura, and S. Miyake: Natural killer T-cell activation by OCH, a sphingosine truncated analogue of -galactosylceramide, prevents collagen-induced arthritis. Arthr Rheumat 50:305-313, 2004
2. Yamamura, T, K. Miyamoto, Zs. Illes, E. Pal, M. Araki, and S. Miyake: NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease. Curr Top Med Chem 4: 561-567, 2004
3. Illes, Zs, M. Shimamura, J. Newcombe, N. Oka, and T. Yamamura: Accumulation of V7.2J33 invariant T cells in autoimmune inflammatory lesions of the nervous system. Int Immunol 16: 223-230, 2004
4. Oki, S, A. Chiba, T. Yamamura and S. Miyake: The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 113: 1631-1640, 2004
5. Miyake, S, A. Chiba and T. Yamamura: Potential of targeting natural killer T cells for the treatment of autoimmune diseases. Mod Rheum 14: 279-284, 2004
6. Satoh, J-i, T. Yamamura, and K. Arima: The 14-3-3 protein isoform, expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis, binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am J Pathol 165: 577-592, 2004
7. Rosen, D.B, M. Araki, J.A. Hamerman, T. Chen, T. Yamamura and L.L. Lanier: A structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol 173: 2470-2478, 2004
8. Takahashi, K, T. Aranami, M. Endoh, S. Miyake, and T. Yamamura: The regulatory role of natural killer cells in multiple sclerosis. Brain 127: 1917-1927, 2004
9. Bedoui, S, S. Miyake, R. Straub, von H?rsten, and T. Yamamura: More sympathy for autoimmunity with neuropeptide Y (NPY)? Trends Immunol 25:508-512, 2004
10. Nakai, Y, K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, K. Watano, T. Mishima, C. Iwabuchi, S. Tanaka, J.S. Bezbradica, T. Nakayama, M. Taniguchi, S. Miyake, T. Yamamura, A. Kitabatake, S. Joyce, L. Van Kaer, and K. Onoe: Natural killer T cells accelerate atherogenesis in mice. Blood 104: 2051-2059, 2004
11. Mizuno, M, M. Masumura, C. Tomi, A. Chiba, S. Oki, T. Yamamura and S. Miyake: Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J Autoimmun 23:293-300, 2004
12. Satoh, J-i, and T. Yamamura: Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol 24:793-814, 2004
13. Hashimoto, D, S. Asakura, S. Miyake, T. Yamamura, L. Van Kaer, C. Liu, M. Tanimoto, and T. Teshima: Stimulation of host natural killer T cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J Immunol 174: 551-556, 2005
14. Ueno, Y, S. Tanaka, M. Sumii, S. Miyake, S. Tazuma, M. Taniguchi, T. Yamamura and K. Chayama: Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of V14 natural killer T cells in mice. Inflamm Bowel Dis 11:35-41, 2005
15. Yu, K.O.A., J.S. Im, A. Molano, Y. Dutronc, P.A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, Y-T. Chang, G.S. Besra, and S.A. Porcelli: Modulation of CD1d-restrotced NKT cell responses by using N-acyl variants of -galactosylceramides. Proc Natl Acad Sci U S A 102: 3383-3388, 2005
16. Satoh, J-i, H. Onoue, K. Arima, and T. Yamamura: Nogo-A and Nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 64: 129-138, 2005
17. Satoh, J-i, M. Nakanishi, F. Koike, S. Miyake, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Kanda, T. Fukazawa and T. Yamamura: Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis 18:537-550, 2005
18. Murata, K, T. Toba, K. Nakanishi, B. Takahashi, T. Yamamura, S. Miyake, and H. Annoura: Total synthesis of an immunosuppressive glycolipid, (2S, 3S, 4R)-1-O-(-D-galactosyl)-2-tetracosanoylamino-1,3,4-nonanetriol. J Org Chem 70: 2398-2401, 2005
19. Chiba, A, S. Kaieda, S. Oki, T. Yamamura and S. Miyake: The involvement of V14 NKT cells in the pathogenesis of murine models of arthritis. Arthr Rheumat 52: 1941-1948, 2005
20. Ota, T, K. Takeda, H. Akiba, Y. Hayakawa, K. Ogasawara, Y. Ikarashi, S. Miyake, H. Wakasugi, T. Yamamura, M. Kronenberg, D.H. Raulet, K. Kinoshita, H. Yagita, M.J. Smyth, and K. Okumura: IFN--mediated negative feedback regulation of NKT cell function by CD94/NKG2. Blood 106: 184-192, 2005
21. Toba, T, K. Murata, T. Yamamura , S. Miyake and H. Annoura: A concise synthesis of (3S, 4S, 5R)-1-(-D-galactopyranosyl)-3-tetracosanoylamino-4,5-decanediol, a C-glycoside analog of immunomodulating -galactosylceramide OCH. Tetrahedron Letters 46: 5043-5047, 2005
22. Ronet, C, S. Darche, M. Leite De Moraes, S. Miyake, T. Yamamura, J. A. Louis, L. H. Kasper, and D. Buzoni-Gatel: NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol 175: 899-908, 2005
23. Croxford, J.L. and T. Yamamura: Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases? J Neuroimmunol 166: 3-18, 2005
24. Miyake, S. and T. Yamamura: Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Curr Drug Targets-Immune, Endocrine and Metabolic Disorders 5: 315-322, 2005
25. Maeda, M, C. Carpenito, R. Russel, J. Dasanjh, L. Veinotte, H. Ohta, T. Yamamura, R. Tan, and F. Takei: Murine CD160, immunoglobulin-like receptor on NK cells and NKT cells, recognizes classical and non-classical MHC class I and regulates NK cell activation. J Immunol 175: 4426-4432, 2005
26. Satoh, J-i, H. Onoue, K. Arima, and T. Yamamura: The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular protein. J Neuropathol Exp Neurol 64 :858-868., 2005
27. Oki, S, C. Tomi, T. Yamamura, and S. Miyake: Preferential Th2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int Immuol 17:1619-1629, 2005
28. Nagayama, S, S. Miyake, and T. Yamamura: Suppression of experimental autoimmune encephalomyelitis by transfer of lymphokine-activated natural killer (NK) cells. Neuroimmunology 13: 239-246, 2005
29. Satoh, J-i, Y. Nanri, and T. Yamamura: Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Methods 152: 278-288, 2006
30. Satoh, J-i, M. Nakanishi, F. Koike, H. Onoue, T. Aranami, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Saito, M. Ohta, S. Miyake, T. Kanda, T. Fukazawa and T. Yamamura: T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J Neuroimmunol 174: 108-118, 2006
31. Satoh, J-i, Y. Nanri, H. Tabunoki, and T. Yamamura: Microarrray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early interferon--responsive genes in peripheral blood lymphocytes: an implication for IFN- related adverse effects in multiple sclerosis. BMC Neurology 6:18, 2006
32. Pyz, E, O. Naidenko, S. Miyake, T. Yamamura, I. Berberich, S. Cardell, M. Kronenberg, and T. Herrmann: The complementarity determining region (CDR) 2 of BV8S2 (Vb8.2) contributes to antigen recognition by rat iNKT TCR. J Immunol 176:7447-55, 2006
33. Satoh, J-i, H. Tabunoki, Y. Nanri, K. Arima, and T. Yamamura: Human astrocytes express 14-3-3 in response to oxidative and DNA-damaging stresses. Neurosci Res 56: 61-72, 2006
34. Croxford, J.L, S. Miyake, Y-Y. Huang, M. Shimamura, and T. Yamamura:@Invariant V19i T cells regulate autoimmune inflammation. Nat Immunol 7: 987 -994, 2006
35. Miyamoto, K, S. Miyake, M. Mizuno, N. Oka, S. Kusunoki, and T. Yamamura: Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2 independent pathway. Brain 129(Pt 8):1984-92, 2006
36. Aranami, T, S. Miyake and T. Yamamura: Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis. J Immunol 177: 5659-5667, 2006

Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry

4-1-1 Ogawa-higashimachi, Kodaira, Tokyo, 187-8502 Japan@@Tel: 042-341-2711@Fax: 042-346-1753

Copyright (C) Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry@ All Rights Rserved.